Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Fri., Apr. 26, 9:05 PM
Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.
| This Slide: #23 of 100 |
Slide #23. Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) — TotipotentRX Corporation
Acquirer:
Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) (NYSE:KOOL)
Acquiree:
TotipotentRX Corporation
Details:
Cesca Therapeutics Inc. (f/n/a ThermoGenesis Corp.) ("Company") (Nasdaq:KOOL) today announced that it consummated the merger with TotipotentRX Corporation ("TotipotentRX") for approximately 12,490,800 shares of the Company's common stock, as contemplated by the previously announced Agreement and Plan of Reorganization (the "Merger Agreement").
Cesca Therapeutics develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. Co. develops and supplies automation technologies for the isolation, purification and storage of stem cells for the cord blood banking industry. Through its ThermoGenesis Corp. subsidiary, Co. provides the AutoXpress® and BioArchive® platforms for automated clinical bio-banking, PXP® platform for point-of-care cell-based therapies and CAR-TXpress™ platform under development for bio-manufacturing for immuno-oncology applications. Co. is also developing autologous cell-based therapies that address needs in the vascular and orthopedic markets.
Open the KOOL Page at The Online Investor »
|
|||||||||
Open the KOOL Page at The Online Investor (in a new window) »
 Free KOOL Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
